Odonate Therapeutics Inc (ODT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ODT

1.12
-0.05 (-4.27%)
At close: Jan 14, 2022
1.11
-0.01 (-0.89%)
After Hours: 1/14/2022, 8:44:12 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ODT. ODT was compared to 190 industry peers in the Pharmaceuticals industry. The financial health of ODT is average, but there are quite some concerns on its profitability. ODT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ODT had negative earnings in the past year.
ODT Yearly Net Income VS EBIT VS OCF VS FCFODT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 -20M -40M -60M -80M -100M

1.2 Ratios

Industry RankSector Rank
ROA -96.5%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ODT Yearly ROA, ROE, ROICODT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ODT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ODT Yearly Profit, Operating, Gross MarginsODT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020

More info and screens

5

2. Health

2.1 Basic Checks

  • ODT has more shares outstanding than it did 1 year ago.
  • ODT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ODT Yearly Shares OutstandingODT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 10M 20M 30M
ODT Yearly Total Debt VS Total AssetsODT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -7.42, we must say that ODT is in the distress zone and has some risk of bankruptcy.
  • ODT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.42
ROIC/WACCN/A
WACCN/A
ODT Yearly LT Debt VS Equity VS FCFODT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 100M -100M

2.3 Liquidity

  • A Current Ratio of 3.29 indicates that ODT has no problem at all paying its short term obligations.
  • A Quick Ratio of 3.29 indicates that ODT has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 3.29
ODT Yearly Current Assets VS Current LiabilitesODT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 31.46% over the past year.
EPS 1Y (TTM)31.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ODT will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.87% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y54.53%
EPS Next 2Y40.68%
EPS Next 3Y25.99%
EPS Next 5Y14.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ODT Yearly EPS VS EstimatesODT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 -1 -2 -3 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • ODT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ODT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ODT Price Earnings VS Forward Price EarningsODT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.58
ODT Per share dataODT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • ODT's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.68%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for ODT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Odonate Therapeutics Inc / ODT FAQ

Can you provide the ChartMill fundamental rating for Odonate Therapeutics Inc?

ChartMill assigns a fundamental rating of 2 / 10 to ODT.


What is the valuation status for ODT stock?

ChartMill assigns a valuation rating of 3 / 10 to Odonate Therapeutics Inc (ODT). This can be considered as Overvalued.


What is the profitability of ODT stock?

Odonate Therapeutics Inc (ODT) has a profitability rating of 1 / 10.


What is the expected EPS growth for Odonate Therapeutics Inc (ODT) stock?

The Earnings per Share (EPS) of Odonate Therapeutics Inc (ODT) is expected to grow by 54.53% in the next year.